Xiao-Ling Yang1,2, Yolandi van der Merwe1,3, Leon C. Ho1,4, Ian P. Conner2,3, Seong-Gi Kim1,5, Kira L. Lathrop2, Gadi Wollstein2,3, Joel S. Schuman2,3, and Kevin C. Chan1,2
1NeuroImaging Laboratory, University of Pittsburgh, Pittsburgh, PA, United States, 2UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, United States, 3Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, United States, 4Department of Electrical and Electronic Engineering, University of Hong Kong, Pokfulam, Hong Kong, 5Center for Neuroscience Imaging Research, Institute for Basic Science, Sungkyunkwan University, Suwon, Korea, Republic of
Synopsis
Glaucoma is the leading cause of irreversible blindness worldwide
and is a slowly progressing neurodegenerative disease of the visual system. While
elevated intraocular pressure (IOP) and age are major risk factors, their
effects on glaucoma pathogenesis remain incompletely understood. In this study,
we determined the onset of glaucomatous changes and their progression in a
chronic inherited glaucoma model using DBA/2J mice. Our results indicate that elevation of IOP
may accelerate the deterioration of structure, physiology and function of the
visual system in the DBA/2J mice across age. Comparatively, the visual system in C57BL/6J mice appeared intact across the same ages.Purpose
Glaucoma is the leading cause of irreversible blindness in
the world and is a slowly progressing neurodegenerative disease of the visual
system. While elevated intraocular pressure (IOP) and age are major risk
factors, their effects on glaucoma pathogenesis are still incompletely
understood [1]. Uncovering the spatiotemporal profiles of glaucoma in the visual
system is important for determining the etiology and pathophysiological events
of the disease and for guiding targeted therapeutic strategy. In this study, we
evaluated the IOP, visuomotor function, anterograde transport and axonal
integrity of the visual system at different ages in a chronic inherited glaucoma
model using DBA/2J (D2) mice, with an aim to probe the onset of glaucomatous
changes and their progression. Age-matched C57BL/6J (B6) mice were assessed as
a control.
Methods
Animal Preparation: Four separate groups of D2 and B6 female mice underwent IOP and
optokinetic assessments at 5 (D2/B6, n=6/5), 7 (n=6/5), 9 (n=6/5) and 12 (n=13/4)
months old (mos). Manganese-enhanced MRI (MEMRI) was performed to a subset of
mice after IOP and optokinetic assessments (n=2-6 per time point per D2/B6
group) and the remaining mice were sacrificed for histological evaluation of
neurofilaments without Mn injection, so as to avoid potential Mn toxicity to
the visual system.
IOP measurements: IOP was
measured using a handheld TonoLab tonometer (Icare, Finland). A total of 18 measurements were
taken and averaged for each eye.
Optokinetics: Visual acuity was quantified using an OptoMotry virtual reality
system (CerebralMechanics, Inc.) to assess the visuomotor behavior [2, 3]. 100%
contrast and rotation speed of 0.12 degrees/s were maintained throughout, while
spatial frequency ranged from 0.042 to 0.750 cycles/degree.
MEMRI:
D2 and B6 mice were intravitreally injected with 0.5μL of 100mM MnCl
2
solution into both eyes and 2D T1-weighted MRI was performed before and 8 hours
after MnCl
2 injection using a 9.4-Tesla Varian/Agilent scanner at
100x100µm
2 in-plane resolution and 0.5mm slice thickness covering
the visual system. A saline syringe phantom was placed next to the mouse head for
signal normalization.
Histological evaluation: D2 and B6 mice
were transcardially perfused with 4% paraformaldehyde. The brains were then
removed and the optic nerves were stained for phosphorylated neurofilaments
(pNF) for confocal microscopy assessments.
Results
The IOP of D2 mice began to increase significantly at
9mos and increased further at 12mos, whereas no apparent IOP change was
observed in B6 mice across age (Figure 1). Visual acuity of D2 mice continued
to worsen from 5 to 9 mos with no apparent difference between 9 and 12 mos
(Figure 2). B6 mice also appeared to perform better than D2 mice at each age
during optokinetic assessments (Figure 2). For MEMRI, similar extents of Mn
enhancement was observed along the visual pathway in the prechiasmatic optic
nerve, lateral geniculate nucleus and superior colliculus of both D2 and B6
mice at 5 and 7 mos (white arrows in Figure 3a). Mn enhancement remained
observable in B6 mice at 9 and 12 mos, but was gradually diminished in D2 mice
at 9 mos and was not noticeable at 12 mos (Figure 3a). Significant reduction in
Mn-enhancement began to be found in the superior colliculus of D2 mice at 9 mos,
which progressed further at 12 mos (Figure 3b). At 12 mos, the optic nerve and
lateral geniculate nucleus also showed reduced Mn enhancement (Figure 3b).
Histological staining of pNF in the optic nerve showed
accumlated signals in D2 mice at 5 and 7 mos
(Figure 4). pNF signal in D2 mice gradually weakened from 5 to 9 mos and was apparently
not noticeable at 12 mos. pNF stain in B6 mice did not show apparent changes across
age from 5 to 12 mos.
Discussion and Conclusions
The spatiotemporal profiles of IOP, visuomotor function, anterograde
transport and axonal integrity in the visual system of both D2 and B6 mice were
characterized. Anterograde Mn transport along the visual pathway in D2 mice
began to be disrupted at the onset of IOP increase at 9 mos and progressed
further at 12 mos along with further IOP increase and neurofilament
loss. Visual acuity in D2 mice appeared to deteriorate earlier than the observable
Mn transport disruption or IOP increase, which suggested additional factors
other than physiological transport or IOP in contributing to
the visuomotor function loss in the current experimental glaucoma model [4-6]. Comparatively, the visual system in B6 mice appeared
relatively intact across age. Overall,
our results indicate that elevation of IOP may accelerate the deterioration of
structure, physiology and function of the visual system in the D2 model of
chronic glaucoma across age.
Acknowledgements
This work was supported by
the National Institutes of Health P30-EY008098 and UL1-TR000005 (Bethesda,
Maryland); BrightFocus Foundation G2013077 (Clarksburg, Maryland), Alcon
Research Institute Young Investigator Grant (Fort Worth, Texas); Eye and Ear
Foundation (Pittsburgh, Pennsylvania); and Research to Prevent Blindness (New
York, New York).References
[1] Susanna, R., Jr., De Moraes,
C.G., Cioffi, G.A. & Ritch, R. Why Do People (Still) Go Blind from
Glaucoma? Transl Vis Sci Technol 4, 1 (2015).
[2] Prusky, GT., Alam, NM., Beekman, S., Douglas, RM., Rapid
quantification of adult and developing mouse spatial vision using a virtual
optomotor system. Invest Ophthalmol Vis
Sci. (2004)
[3] Douglas, RM., Alam, NM., Silver, BD., McGill, TJ.,
Tschetter, WW., Prusky, GT. Independent visual threshold measurements in the
two eyes of freely moving rats and mice using a virtual-reality optokinetic
system. Vis Neurosci,5 (2005)
[4] Wilson GN, Inman DM, Denger-Crish CM, Smith MA, Crish
SD. Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of
glaucoma. Journal of neuroinflammation 2015;12(1):176.
[5] Bosco A, Steele MR, Vetter ML. Early microglia
activation in a mouse model of chronic glaucoma. J Comp Neurol
2011;519(4):599-620.
[6] Bosco A, Romero CO, Breen KT, Chagovetz AA, Steele MR,
Ambati BK, Vetter ML. Neurodegeneration severity can be predicted from early
microglia alterations monitored in vivo in a mouse model of chronic glaucoma.
Disease models & mechanisms 2015;8(5):443-455.